Vitiligo Clinical Trial

Do you have vitiligo? You may be eligible to participate in a clinical research study of an investigational therapy, afamelanotide.
Eligible patients will receive either narrowband UVB (NB-UVB) light therapy in combination with afamelanotide, or NB-UVB alone.
If you: • Have vitiligo on your face and body • Have a medium to dark skin type • Are aged 12+ • Are able to attend up to 14 clinic visits over 12 months Then you may be eligible to participate.
There is no cost to participate and participants may be eligible for travel reimbursements.
To register your interest and learn more, copy/paste the link below: https://www.
clinuvel.
com/cuv105-phase-iii-clinical-trial-in-vitiligo